Integrative Genomic Analyses Identify COL21A1 and ENPEP-FGF5 Regulatory Pathways for Blood Pressure Variation in East Asians
Zhi Chng LauiD, Xuling ChangiD, Kar Seng SimiD, Hao WuiD, Arshia NaaziD, Umamaheswari MuniasamyiD, Chiea-Chuen Khor, Woon-Puay KohiD, Sorokin Vitaly, Rajkumar DorajooiD
Abstract
BackgroundHypertension is a highly heritable cardiovascular disorder and a major determinant of cardiometabolic disease, including diabetes. However, the regulatory genes and tissue-specific mechanisms underlying blood pressure variations remain incompletely understood. MethodsLeveraging a well-characterized prospective population-based cohort comprised of 27,308 participants from the Singapore Chinese Health Study (SCHS), we evaluated genome-wide genetic associations for five blood pressure traits: hypertension status, systolic blood pressure, diastolic blood pressure, mean arterial pressure (MAP) and pulse pressure (PP). Additionally, we conducted a transcriptome-wide association study (TWAS), integrating gene expression data from 49 tissues, followed by colocalization and fine-mapping to prioritize regulatory genes. Association of identified variants with incident diabetes was additionally evaluated in the longitudinal data. ResultsWe validated 10 blood pressure loci (P between 1.64 x 10-20 - 4.10 x 10-8) and identified an East-Asian specific splice donor variant at the COL21A1 gene associated with PP (rs149344559, P = 6.78 x 10-10). Integrative analyses prioritized FGF5 in kidney cortex and ENPEP in pituitary tissue as candidate regulatory genes. The blood pressure-lowering allele at ENPEP (T allele, rs1879056) was associated with reduced risk of incident diabetes. Mediation analysis demonstrated that approximately 21% of the genetic association with diabetes was mediated through MAP (Pindirect-effect = 2 x 10-16). ConclusionThis study refines genetic predispositions for blood pressure among East-Asians. We further delineate tissue-specific regulatory pathways underlying blood pressure variations and identify ENPEP-mediated dysfunctions linking blood pressure genetics to diabetes risk, underscoring integrated disease mechanisms.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Integration of genetic fine-mapping and multi-omics data reveals candidate effector genes for hypertension
Stefan van Duijvenboden, Julia Ramírez, … Patricia B. Munroe·The American Journal of Human GeneticsPeer-reviewed·Sep 7, 2023
- Identification of the molecular components of enhancer-mediated gene expression variation in multiple tissues regulating blood pressure
Or Yaacov, Prabhu Mathiyalagan, … Aravinda Chakravarti·HypertensionPeer-reviewed·May 15, 2024
- Genetic analysis of over one million people identifies 535 novel loci for blood pressure.
E. Evangelou, H. R. Warren, … Verwe·bioRxiv·Oct 11, 2017
- Novel blood pressure locus and gene discovery using GWAS and expression datasets from blood and the kidney
Louise V. Wain, Ahmad Vaez, … Tamara B. Harris·HypertensionPeer-reviewed·Jul 24, 2017
- Association analyses of predicted loss-of-function variants prioritized 15 genes as blood pressure regulators
Estelle Lecluze, Guillaume Lettre·Canadian Journal of CardiologyPeer-reviewed·Jul 12, 2023
- Tissue-specific and tissue-agnostic effects of genome sequence variation modulating blood pressure
Dongwon Lee, Seong Kyu Han, … Aravinda Chakravarti·Cell ReportsPeer-reviewed·Nov 1, 2023